All Articles

Amir Wain's recent Stevie Award isn't just a trophy; it's a validation of a decades-old architectural bet that positions i2c far ahead in the AI race.

A small Canadian firm is partnering with the nation's top research body to turn a unique Greenlandic mineral into a powerful new tool for CO2 removal.

The BankFinancial conversion is more than new signs on old branches. It's a deep dive into First Financial's disciplined, tech-fueled Midwest expansion plan.

As AI assistants flood software development, New Relic's new tool promises to bring order, visibility, and governance to a fragmented and unmonitored frontier.

By acquiring Rotate°, the design and tech giant is betting that modular, AI-powered systems are the key to unlocking the next decade of brand growth.

Pushpay's new integration with Nurture.io isn't just a software update; it's a blueprint for how data can foster genuine human connection at scale.

As Infortar tightens its grip on Tallink, the move signals more than control—it's a masterclass in long-term value creation in a volatile world.

With its founder stepping back and a new CRO from a top rival, Pebl's leadership overhaul is more than a shuffle—it's a calculated bet on AI and compliance.

A new medical AI, trained on vast proprietary data, is now live in a US clinic. It reasons like a physician, not a scribe, setting a new bar for trust and accuracy.

The pest control specialist's Nasdaq debut is more than a ticker change. It’s a calculated gambit to tap U.S. capital and scale a resilient, niche industry.

As the RWA market accelerates, Auxite’s new platform for gold, silver, platinum, and palladium bets on verifiable ownership over simple price exposure.

Consolidated Water's appointment of Sachin Chawla signals a major strategic shift, leveraging his deep expertise from massive projects to fuel an aggressive expansion.

With a new $4.3B war chest, Hunter Point Capital is evolving from a GP stakes firm into a scaled solutions platform, meeting a critical need for liquidity.

A landmark drug approval in China offers new hope for IgAN patients. But the real story is how science, strategy, and policy are converging to build a better future.

Griffon Corporation is offloading its AMES Australasia unit, but this is no fire sale. It’s a calculated JV that nets cash now and retains future upside.

By becoming the exclusive insurance partner for Huawei's luxury EVs, SunCar is embedding its AI platform deep within a new automotive power structure.

The firm's high-level hires from rival firms signal a calculated move to dominate the lucrative credit and opportunistic investment landscape amid market shifts.

HUHUTECH is pivoting from engineering services to building its own semiconductor gear, a move that could reshape its future and tap into China's tech self-sufficiency drive.

As AI demos flood Automate 2026, Datanomix stands out by proving its AI is already working, democratizing advanced analytics for manufacturers of all sizes.

Conexeu Sciences hits a key manufacturing milestone for its innovative wound-healing gel, but the path to FDA clearance and a crowded market remains a challenge.